268 Mrv0541 02231214332D 19 20 0 0 0 0 999 V2000 6.5951 -1.6938 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 1.1938 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.2886 -2.3577 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 0.3688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -0.0437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -0.8687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 1.6063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 1.6063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 -1.2813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2886 -1.0298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 -2.1063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 2.4313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 2.4313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -1.2813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7701 -1.6938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 -2.5188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -2.1063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 2.8438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 2.8438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 15 2 0 0 0 0 2 4 1 0 0 0 0 2 7 1 0 0 0 0 2 8 1 0 0 0 0 3 11 1 0 0 0 0 3 15 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 9 2 0 0 0 0 6 14 1 0 0 0 0 7 12 1 0 0 0 0 8 13 1 0 0 0 0 9 10 1 0 0 0 0 9 11 1 0 0 0 0 10 15 1 0 0 0 0 11 16 2 0 0 0 0 12 18 1 0 0 0 0 13 19 1 0 0 0 0 14 17 2 0 0 0 0 16 17 1 0 0 0 0 M END > T3D2731 > t3db > CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1 > InChI=1S/C16H24N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15/h5-7H,3-4,8-12H2,1-2H3,(H,17,19) > UHSKFQJFRQCDBE-UHFFFAOYSA-N > C16H24N2O > 260.3746 > 260.1888634 > 2 > 31.19349866501594 > 1 > 1 > 0 > 1 > 4-[2-(dipropylamino)ethyl]-2,3-dihydro-1H-indol-2-one > 3.16 > 3.0607688583333332 > -2.87 > 0 > 2 > 1 > 15.550650015545543 > 13.235697578459842 > 10.172217699351425 > 32.34 > 81.4278 > 7 > 1 > 3.53e-01 g/l > ropinirole > 1 > T3D2731 > Ropinirole > 91374-21-9 > Adartrel; ReQuip; ReQuip CR; ReQuip XL; Ronirol; Ropinirol; Ropinirolum > Organic Compound; Amine; Amide; Drug; Central Nervous System Agent; Antiparkinson Agent; Antidyskinetic; Dopamine Agonist; Metabolite; Synthetic Compound $$$$